IL97211A - A medicinal product containing bisoprolol and activating the potassium channel - Google Patents

A medicinal product containing bisoprolol and activating the potassium channel

Info

Publication number
IL97211A
IL97211A IL9721191A IL9721191A IL97211A IL 97211 A IL97211 A IL 97211A IL 9721191 A IL9721191 A IL 9721191A IL 9721191 A IL9721191 A IL 9721191A IL 97211 A IL97211 A IL 97211A
Authority
IL
Israel
Prior art keywords
bisoprolol
pharmaceutical composition
channel activator
potassium channel
acceptable salts
Prior art date
Application number
IL9721191A
Other languages
English (en)
Hebrew (he)
Other versions
IL97211A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL97211A0 publication Critical patent/IL97211A0/xx
Publication of IL97211A publication Critical patent/IL97211A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL9721191A 1990-02-13 1991-02-11 A medicinal product containing bisoprolol and activating the potassium channel IL97211A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4004268A DE4004268A1 (de) 1990-02-13 1990-02-13 Pharmazeutische zubereitung

Publications (2)

Publication Number Publication Date
IL97211A0 IL97211A0 (en) 1992-08-18
IL97211A true IL97211A (en) 1995-07-31

Family

ID=6399970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9721191A IL97211A (en) 1990-02-13 1991-02-11 A medicinal product containing bisoprolol and activating the potassium channel

Country Status (16)

Country Link
EP (1) EP0442141B1 (pt)
JP (1) JPH04234813A (pt)
KR (1) KR910015294A (pt)
AT (1) ATE102031T1 (pt)
AU (1) AU642961B2 (pt)
CA (1) CA2036091A1 (pt)
DE (2) DE4004268A1 (pt)
DK (1) DK0442141T3 (pt)
ES (1) ES2062287T3 (pt)
HU (1) HU208483B (pt)
IE (1) IE64207B1 (pt)
IL (1) IL97211A (pt)
NO (1) NO910566L (pt)
NZ (1) NZ237092A (pt)
PT (1) PT96719A (pt)
ZA (1) ZA911074B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209071A1 (de) * 1992-03-20 1993-09-23 Merck Patent Gmbh Pharmazeutische zubereitung
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
CA2036091A1 (en) 1991-08-14
PT96719A (pt) 1991-10-31
EP0442141B1 (de) 1994-03-02
NO910566L (no) 1991-08-14
DK0442141T3 (da) 1994-03-28
HU208483B (en) 1993-11-29
ATE102031T1 (de) 1994-03-15
DE4004268A1 (de) 1991-08-14
ES2062287T3 (es) 1994-12-16
IL97211A0 (en) 1992-08-18
IE64207B1 (en) 1995-07-12
JPH04234813A (ja) 1992-08-24
AU7102991A (en) 1991-08-15
DE59004798D1 (de) 1994-04-07
IE910473A1 (en) 1991-08-14
ZA911074B (en) 1991-11-27
HUT59593A (en) 1992-06-29
AU642961B2 (en) 1993-11-04
EP0442141A1 (de) 1991-08-21
KR910015294A (ko) 1991-09-30
HU910463D0 (en) 1991-08-28
NO910566D0 (no) 1991-02-12
NZ237092A (en) 1993-01-27

Similar Documents

Publication Publication Date Title
US5643936A (en) Treatments for diseases characterized by neovascularization
DE69930243T2 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
EP0236684A2 (en) Galanthamine or analogues thereof for treating Alzheimer's disease
US5849740A (en) Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
CA2212412A1 (en) Deprenyl compounds for treatment of glaucoma
DE69721838T2 (de) 1-[1-(4-chlorphenyl)cyclobutyl]-3-methylbutyl amin derivate zur senkung von harnsäurespiegeln beim menschen
DE3043502A1 (de) Analoga von lincomycin und clindamycin
DE69826561T2 (de) Aldose Reductase Hemmung zur Vorbeugung oder zur Umkehrung der diabetischen Kardiomyopathie
EP0010156B1 (de) 6-Arylpyridazin-3-one, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
EP0166183B1 (de) Verwendung von Hydroxyindolderivaten zur Herstellung eines Arzneimittels zur Senkung des Blutdrucks
IL97211A (en) A medicinal product containing bisoprolol and activating the potassium channel
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
US3329567A (en) Synergistic effect of adenylic nucleotides in digitalis therapy
CH649918A5 (de) Verwendung von n-amidino-2-phenylacetamiden als wirkstoff zur herstellung von pharmazeutischen zubereitungen gegen schizophrenie.
EA006776B1 (ru) Фармацевтическая композиция для лечения диабетической невропатии
EP0109623B1 (de) Phenylpropanolamine, ihre Herstellung und Verwendung
DE69013476T2 (de) Anwendung von Naphthoxazinen.
EP0401505A2 (de) Pharmazeutische Zubereitung mit einem Kaliumkanalaktivator und einem ACE-Hemmer
CA1288347C (en) Pharmaceutical compositions for the treatment of intermittent claudication
DE69214728D1 (de) Dithian substituierte Retinoide, ihre Verwendung, Verfahren zu ihrer Herstellung, diese enthaltende kosmetische und pharmazeutische Zusammensetzungen und ihre therapeutische Verwendung
WO1988001998A1 (en) Hydroxylindol derivatives
DE3687448T2 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.
AT389446B (de) Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
EP0398171A2 (de) Verwendung von Imidazodiazepinen bei der Behandlung von neurologischen Symptomen, welche mit zirkulatorischen Störungen des Gehirns assoziiert sind
DE3314142C2 (pt)

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent

Free format text: 31.10.95